T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19
Open Access
- 27 March 2022
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 78, 103967
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed IndividualsCell, 2020
- Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysisJournal of Intensive Care, 2020
- Primary immunodeficiencyAllergy, Asthma & Clinical Immunology, 2018
- TNF activity and T cellsCytokine, 2018
- Evaluation of a novel automated volumetric flow cytometer for absolute CD4+ T lymphocyte quantitationCytometry Part B: Clinical Cytometry, 2016
- Flow cytometric evaluation of lymphocyte transformation test based on 5-ethynyl-2′deoxyuridine incorporation as a clinical alternative to tritiated thymidine uptake measurementJournal of Immunological Methods, 2014
- Inter‐laboratory assessment of flow cytometric monocyte HLA‐DR expression in clinical samplesCytometry Part B: Clinical Cytometry, 2012
- Primary immunodeficienciesJournal of Allergy and Clinical Immunology, 2010
- T cell vaccines for microbial infectionsNature Medicine, 2005
- New Methods for Assessing T-Cell ResponsesClinical and Diagnostic Laboratory Immunology, 2000